Last update:

HIV & AIDS news

Medications

Gilead licenses HIV-prevention drug to generic drugmakers

US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

HIV not as infectious soon after transmission as thought (Update)

People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters ...

HIV & AIDS

Cellular scissors chop up HIV virus

Imagine a single drug that could prevent human immunodeficiency virus (HIV) infection, treat patients who have already contracted HIV, and even remove all the dormant copies of the virus from those with the more advanced ...

HIV & AIDS

Novel tool visualizes whole body SIV replication

A collaborative effort between investigators at the Yerkes National Primate Research Center, Emory University School of Medicine and Georgia Institute of Technology has led to the development of a non-invasive method to image ...

HIV & AIDS

More otologic symptoms, hearing loss for HIV-infected

(HealthDay)—Otologic symptoms and hearing loss are more common among patients with HIV than uninfected controls, according to a study published online March 5 in JAMA Otolaryngology—Head & Neck Surgery.

HIV & AIDS

Research captures transient details of HIV genome packaging

Once HIV-1 has hijacked a host cell to make copies of its own RNA genome and viral proteins, it must assemble these components into new virus particles. The orchestration of this intricate assembly process falls to a viral ...

HIV & AIDS

Preventing one case of HIV saves over $225K, study shows

How much money would be saved if one high-risk person was prevented from contracting HIV in the United States? A new study led by a researcher at Weill Cornell Medical College and published online Feb. 24 in Medical Care, ...

HIV & AIDS

Could an HIV drug beat strep throat, flesh-eating bacteria?

With antibiotic resistance on the rise, scientists are looking for innovative ways to combat bacterial infections. The pathogen that causes conditions from strep throat to flesh-eating disease is among them, but scientists ...

HIV & AIDS

Web app prompts important sexual health testing

A personalized web app designed to encourage young men at risk for sexually transmitted diseases to go for testing has proven successful in a small trial conducted in Southeast Michigan.

HIV & AIDS

Merck grants free license for pediatric HIV drug

(AP)—Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.

HIV & AIDS

'Remission' replaces 'functional cure' in HIV case

(HealthDay)—All babies born with HIV should receive the same rapid medical response as the young Mississippi girl born with the virus who suffered a disappointing relapse last July, despite the fact that the virus later ...

HIV & AIDS

Court: Not disclosing HIV before sex is a misdemeanor

New York's highest court says an HIV-positive man who told a partner that they could safely have unprotected sex should face a misdemeanor reckless endangerment charge, not a felony.

HIV & AIDS

Researchers trial new HIV prevention method

Scientists at the University of York, in conjunction with the York Clinical Research Facility, will start the first phase of trials looking into a new way to prevent HIV transmission.

HIV & AIDS

HIV vaccine trial launches in South Africa

A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen ...